Evidence map›Paper›PMID 42123583›Full record

ArticleInternational journal of molecular sciences2026

Regulation of Tau Alternative Splicing: A Novel Role for the Ribonucleoprotein RBM20.

Andrea Corsi, Angela Valentino, Maria Giusy Bruno, Giacomo Menichetti, Francesca Belpinati, Marta P Pereira, Maria Teresa Valenti, Alessandra Ruggiero, Elisabetta Trabetti, Cristina Bombieri and 1 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Andrea CorsiDepartment of Neuroscience, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.ORCID 0000-0001-7482-3251
Angela ValentinoDepartment of Neuroscience, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.ORCID 0009-0001-8486-2809
Maria Giusy BrunoDepartment of Neuroscience, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.ORCID 0009-0003-5018-4311
Giacomo MenichettiDepartment of Neuroscience, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.ORCID 0009-0002-1430-3638
Francesca BelpinatiDepartment of Neuroscience, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.
Marta P PereiraDepartamento de Biología Molecular, Instituto Universitario de Biología Molecular (IUBM) and Centro de Biología Molecular Severo Ochoa (CBMSO), Universidad Autónoma de Madrid, 28049 Madrid, Spain.
Maria Teresa ValentiDepartment of Neuroscience, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.ORCID 0000-0003-1166-8033
Alessandra RuggieroDepartment of Neuroscience, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.
Elisabetta TrabettiDepartment of Neuroscience, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.ORCID 0000-0003-3822-7166
Cristina BombieriDepartment of Neuroscience, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.ORCID 0000-0003-0295-5938
Maria Grazia RomanelliDepartment of Neuroscience, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.ORCID 0000-0002-7360-1195

Funding

Associazione Giovanna Tosi per la lotta contro i tumori Young Research Mobility Program 2023European Commission HORIZON-EIC-2021-PATHFINDEROPEN-01 project 101047177 OpenMINDMinistry of Universities and Research Excellence Project 2023-2027 of the Department of Neuroscience, Biomedicine and Movement Sciences of the University of Verona
6 · The paper itself

Abstract

Tau is a protein associated with microtubules principally expressed in neuronal cells, where it plays a fundamental role in cytoskeleton stabilization and axonal transport. Several diseases collectively named tauopathies, such as Alzheimer's disease, have been associated with an imbalance in the expression of alternative spliced Tau transcripts and the accumulation of hyperphosphorylated Tau, causing dysfunction and death of neuronal cells. Therefore, understanding the Tau exon splicing mechanisms may contribute to elucidating molecular factors that could underlie the development of neurodegenerative disorders. The aim of this study was to define the role of selected splicing factors in regulating Tau exon expression in cell lines and neuronal organoids. We demonstrated the role of the RNA-binding motif protein 20 (RBM20) splicing factor in regulating Tau exon 6 and exon 10, applying RNA-binding assay and qPCR analyses. Furthermore, we demonstrated that Tau expression was regulated during cerebral organoid differentiation, recapitulating in vivo Tau expression. These results suggest the feasibility of using brain organoid technology to study Tau alternative splicing during neural development, confirming that 3D cellular models could be used to study and characterize pathological processes taking place in Tau-related pathologies.

Indexed as

Alternative SplicingRNA-Binding Proteinstau ProteinsAnimalsCell DifferentiationExonsHumansMiceNeuronsRNA-Binding Proteinstau Proteinsalternative splicingMAPTPTBP1RBM20Tau

Identifiers

PMID42123583
PMCPMC13164133

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.